Jawad Ahmad, MD
img_Jawad Ahmad
PROFESSOR | Medicine, Liver Diseases
Are you a patient?
Specialties
Liver Transplantation
Research Topics
Liver, Transplantation
Dr Jawad Ahmad is co Primary Investigator on NIH/NIDDK research initiative to study cases of severe liver injury caused by caused by prescription drugs, over-the-counter drugs, and alternative medicines, such as herbal products and supplements.  For more information  on the Drug-Induced Liver Injury Network (DILIN) visit: https://dilin.dcri.duke.edu/

MD, Royal Free Hospital School of Medicine

Residency, Internal Medicine, Renaissance School of Medicine at Stony Brook University

Fellowship, Transplant Hepatology, University of Pittsburgh Medical Center

Certifications

American Board of Internal Medicine
Publications

Selected Publications

Key steps of complex robotic liver surgery: an international expert survey. Noa L.E. Aegerter, Christoph Kuemmerli, Felix Nickel, Cristiano Guidetti, Christoph Tschuor, Victor Lopez-Lopez, Taiga Wakabayashi, Philipp Dutkowski, Adrian T. Billeter, Beat P. Müller, Philip C. Müller, Roeland de Wilde, Go Wakabayashi, Roberto I. Troisi, Christian Toso, Rutger Jan Swijnenburg, Roberto I. Sutcliffe, Iswanto Sucandy, Benjamin Strücker, Stefan Stättner, Patrick Starlinger, Olivier Soubrane, Daniel Seehofer, Moritz Schmelzle, Olivier Scatton, Olivier Saint-Marc, Ricardo Robles-Campos, Christoph Reissfelder, Francesca Ratti, Nuh Rahbari, Florian Primavesi, Johann Pratschke, Hugo Pinto Marques, James Park, Fabrizio Panaro, Christian E. Oberkofler, Yutaka Nakano, Riccardo Memeo, John B. Martinie, Marcel Machado, Georg Lurje, Charles Chung Wei Lin, Chetana Lim, Mickael Lesurtel, Jae Hoon Lee, Philipp Kron, Yoshikuni Kawaguchi, Jan Philipp Jonas, Mathieu D’Hondt, Jawad Ahmad. Surgical Endoscopy

Liver Injury Due to Intravenous Methylprednisolone—An Under-Recognised Entity. Jawad Ahmad, Jay H. Hoofnagle. Liver International

Investigation of the Role of Chemical Analysis in Causality Assessment of Herbal and Dietary Supplement-Induced Liver Injury. Dina Halegoua-DeMarzio, Victor J. Navarro, Ashley Davis, Jawad Ahmad, Bharathi Avula, Huiman Barnhart, A. Sidney Barritt, Herbert L. Bonkovsky, Vincent L. Chen, Gina Choi, Robert J. Fontana, Marwan S. Ghabril, Ikhlas Khan, Christopher Koh, Joseph Odin, Don C. Rockey, Hoss Rostami, Jose Serrano, Averell H. Sherker, Andrew Stolz, Hans L. Tillmann, Raj Vuppalanchi. Drug Safety

View All Publications

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Ahmad has not yet completed reporting of Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.